Search Results - "Thiriot, David"

Refine Results
  1. 1
  2. 2
  3. 3

    Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination by Wang, Su, Rustandi, Richard R, Lancaster, Catherine, Hong, Laura G, Thiriot, David S, Xie, Jinfu, Secore, Susan, Kristopeit, Adam, Wang, Sheng-Ching, Heinrichs, Jon H

    Published in Vaccine (04-03-2016)
    “…Highlights • Clostridium difficile binary toxins (CDTa and CDTb) are lethal in mice and hamsters. • Mice can be used as animal model to evaluate toxicity for…”
    Get full text
    Journal Article
  4. 4

    Meeting report VLPNPV: Session 8: Vaccines I by Thiriot, David S

    Published in Human vaccines & immunotherapeutics (01-10-2014)
    “…In Session 8 of the recent conference "Virus-Like Particle and Nano-Particle Vaccines" held at the Salk Institute in La Jolla, California (05 June 2014), four…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Ion-Exchange Chromatography to Analyze Components of a Clostridium difficile Vaccine by Rustandi, Richard R, Wang, Feng, Lancaster, Catherine, Kristopeit, Adam, Thiriot, David S, Heinrichs, Jon H

    “…Ion-exchange (IEX) chromatography is one of many separation techniques that can be employed to analyze proteins. The separation mechanism is based on a…”
    Get more information
    Journal Article
  6. 6

    Influence of formulation pH and suspension state on freezing-induced agglomeration of aluminum adjuvants by Salnikova, Maya S, Davis, Harrison, Mensch, Christopher, Celano, Lauren, Thiriot, David S

    Published in Journal of pharmaceutical sciences (01-03-2012)
    “…Freezing and thawing of vaccines containing aluminum adjuvants can lead to formation of aggregates and loss in vaccine potency. We sought to understand whether…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Development of a recombinant toxin fragment vaccine for Clostridium difficile infection by Karczewski, Jerzy, Zorman, Julie, Wang, Su, Miezeiewski, Matthew, Xie, Jinfu, Soring, Keri, Petrescu, Ioan, Rogers, Irene, Thiriot, David S, Cook, James C, Chamberlin, Mihaela, Xoconostle, Rachel F, Nahas, Debbie D, Joyce, Joseph G, Bodmer, Jean-Luc, Heinrichs, Jon H, Secore, Susan

    Published in Vaccine (19-05-2014)
    “…Abstract Clostridium difficile infection (CDI) is the major cause of antibiotic-associated diarrhea and pseudomembranous colitis, a disease associated with…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant by Wang, Bei, Wang, Su, Rustandi, Richard R, Wang, Feng, Mensch, Christopher D, Hong, Laura, Kristopeit, Adam, Secore, Susan, Dornadula, Geethanjali, Kanavage, Anthony, Heinrichs, Jon H, Mach, Henryk, Blue, Jeffrey T, Thiriot, David S

    Published in Vaccine (01-01-2015)
    “…Highlights • A C. difficile toxin B mutant with five mutations (mTcdB) has residual toxicity. • Formaldehyde can remove residual toxicity but reversion in…”
    Get full text
    Journal Article
  10. 10

    Structure of the Coat Protein in Pf1 Bacteriophage Determined by Solid-state NMR Spectroscopy by Thiriot, David S., Nevzorov, Alexander A., Zagyanskiy, Lena, Wu, Chin H., Opella, Stanley J.

    Published in Journal of molecular biology (13-08-2004)
    “…The atomic resolution structure of Pf1 coat protein determined by solid-state NMR spectroscopy of magnetically aligned filamentous bacteriophage particles in…”
    Get full text
    Journal Article
  11. 11

    Flavodoxin Hydroquinone Reduces Azotobacter vinelandii Fe Protein to the All-Ferrous Redox State with a S = 0 Spin State by Lowery, Thomas J., Wilson, Phillip E., Zhang, Bo, Bunker, Jared, Harrison, Roger G., Nyborg, Andrew C., Thiriot, David, Watt, Gerald D.

    “…Azotobacter vinelandii flavodoxin hydroquinone (FIdHQ) is a physiological reductant to nitrogenase supporting catalysis that is twice as energy efficient…”
    Get full text
    Journal Article
  12. 12

    Dipolar Waves Map the Structure and Topology of Helices in Membrane Proteins by Mesleh, Michael F, Lee, Sangwon, Veglia, Gianluigi, Thiriot, David S, Marassi, Francesca M, Opella, Stanley J

    Published in Journal of the American Chemical Society (23-07-2003)
    “…Dipolar waves describe the structure and topology of helices in membrane proteins. The fit of sinusoids with the 3.6 residues per turn period of ideal…”
    Get full text
    Journal Article
  13. 13

    Structural basis of the temperature transition of Pf1 bacteriophage by Thiriot, David S., Nevzorov, Alexander A., Opella, Stanley J.

    Published in Protein science (01-04-2005)
    “…The filamentous bacteriophage Pf1 undergoes a reversible temperature‐dependent transition that is also influenced by salt concentrations. This structural…”
    Get full text
    Journal Article
  14. 14

    Identification of Human Vesicle Monoamine Transporter (VMAT2) Lumenal Cysteines That Form an Intramolecular Disulfide Bond by Thiriot, David S, Sievert, Michael K, Ruoho, Arnold E

    Published in Biochemistry (Easton) (21-05-2002)
    “…The vesicle monoamine transporter (VMAT2) concentrates monoamine neurotransmitter into synaptic vesicles. To obtain structural information regarding this large…”
    Get full text
    Journal Article
  15. 15

    Probing the Salmeterol Binding Site on the β2-Adrenergic Receptor Using a Novel Photoaffinity Ligand, [125I]Iodoazidosalmeterol by Rong, Yajing, Arbabian, Marty, Thiriot, David S, Seibold, Anita, Clark, Richard B, Ruoho, Arnold E

    Published in Biochemistry (Easton) (31-08-1999)
    “…Salmeterol is a long-acting β2-adrenergic receptor (β2AR) agonist used clinically to treat asthma. In addition to binding at the active agonist site, it has…”
    Get full text
    Journal Article
  16. 16

    Mutagenesis and Derivatization of Human Vesicle Monoamine Transporter 2 (VMAT2) Cysteines Identifies Transporter Domains Involved in Tetrabenazine Binding and Substrate Transport by Thiriot, David S., Ruoho, Arnold E.

    Published in The Journal of biological chemistry (20-07-2001)
    “…The vesicle monoamine transporter (VMAT2) concentrates monoamine neurotransmitter into synaptic vesicles. Photoaffinity labeling, chimera analysis, and…”
    Get full text
    Journal Article
  17. 17

    Detecting and preventing reversion to toxicity for a formaldehyde-treatedC. difficiletoxin B mutant by Wang, Bei, Wang, Su, Rustandi, Richard R, Wang, Feng, Mensch, Christopher D, Hong, Laura, Kristopeit, Adam, Secore, Susan, Dornadula, Geethanjali, Kanavage, Anthony, Heinrichs, Jon H, Mach, Henryk, Blue, Jeffrey T, Thiriot, David S

    Published in Vaccine (01-01-2015)
    “…The toxicity ofClostridium difficilelarge clostridial toxin B (TcdB) can be reduced by many orders of magnitude by a combination of targeted point mutations…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Development of a recombinant toxin fragment vaccine forClostridium difficileinfection by Karczewski, Jerzy, Zorman, Julie, Wang, Su, Miezeiewski, Matthew, Xie, Jinfu, Soring, Keri, Petrescu, Ioan, Rogers, Irene, Thiriot, David S, Cook, James C, Chamberlin, Mihaela, Xoconostle, Rachel F, Nahas, Debbie D, Joyce, Joseph G, Bodmer, Jean-Luc, Heinrichs, Jon H, Secore, Susan

    Published in Vaccine (19-05-2014)
    “…Clostridium difficileinfection (CDI) is the major cause of antibiotic-associated diarrhea and pseudomembranous colitis, a disease associated with significant…”
    Get full text
    Journal Article
  20. 20

    High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells by Sievert, M K, Thiriot, D S, Edwards, R H, Ruoho, A E

    Published in Biochemical journal (01-03-1998)
    “…The full-length cDNA for the rat synaptic-vesicle monoamine transporter (VMAT2) containing a C-terminal polyhistidine epitope has been engineered into…”
    Get full text
    Journal Article